Breast Cancer
Hormonal (aromatase inhibitor) therapy used in hormone receptor-positive breast cancer in postmenopausal women.
Medicines (1)
Browse by Diagnosis
Each cancer type lists the medicines in our range that are approved for it. Your oncologist decides which treatment, dose and duration are right for you.
Hormonal (aromatase inhibitor) therapy used in hormone receptor-positive breast cancer in postmenopausal women.
Medicines (1)
Targeted tyrosine kinase inhibitors used in advanced renal cell carcinoma.
Medicines (4)
Targeted therapy used in unresectable hepatocellular carcinoma.
Medicines (1)
Targeted therapy used in progressive differentiated thyroid carcinoma that no longer responds to radioactive iodine.
Medicines (1)
Targeted therapy used in GIST after disease progression on, or intolerance to, imatinib.
Medicines (1)
Targeted therapy used in advanced soft tissue sarcoma in patients who have received prior chemotherapy.
Medicines (2)
Targeted therapy used in progressive, well-differentiated pancreatic neuroendocrine tumours.
Medicines (1)
Patients & Caregivers
Share your prescription with our team and we'll confirm availability, pack size and delivery for you.
Hospitals, Clinics & Pharmacies
Dependable supply of oncology medicines for institutions, with documentation available on request.
Partner with usMedical disclaimer: Information on this website is for general reference only and is not a substitute for professional medical advice. Oncology medicines must be used only under the supervision of a qualified oncologist and are supplied against a valid prescription.